Prophylactic use of voriconazole in children at high risk of invasive fungal infections.

Document Type : Original Articles

Authors

1 Infectious Diseases Specialist, –°hief of Infection Control Department; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Borovlyany, Minsk region, Republic of Belarus

2 Scientific Department, Junior Researcher, Laboratory of Genetic Biotechnology; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Borovlyany, Minsk region, Republic of Belarus

3 Scientific Department, Researcher, Laboratory of Genetic Biotechnology; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Borovlyany, Minsk region, Republic of Belarus

4 Biologist, Group of Molecular Biology and Transplant Processing; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Borovlyany, Minsk region, Republic of Belarus

5 Leading Engineer of Automated Control Systems Department; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Borovlyany, Minsk region, Republic of Belarus

6 Scientific Department, Researcher, Laboratory of Molecular and Genetic Research; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Borovlyany, Minsk region, Republic of Belarus

7 Corresponding Member of the National Academy of Sciences of Belarus, Scientific Department, Senior Researcher, Laboratory of Cellular Biotechnology and Cytotherapy; Belarusian Research Center for Pediatric Oncology, Hematology and

Abstract

Not ready to published